Search results for: 'companion diagnostics dell and alliance of 2022'
- Did you mean
- companion diagnostics deal and alliance of 2020
- Related search terms
- companion diagnostics partnering test and agreements
- companion diagnostics partnering terms rad
- companion diagnostics partnering test report
- companion diagnostics partnering texas recor
- companion diagnostics partnering terms raw
-
Discovery Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2026March 2026$4,995.00The Discovery Stage Partnering Terms and Agreements in Pharma and Biotech (2020-2026) report offers in-depth insights and exclusive access to discovery-stage partnering agreements signed by the world’s leading biopharma companies, providing a detailed analysis of deal structures, financial terms and strategic collaborations.
Learn More -
Collaboration Deals in Pharmaceuticals 2020-2026March 2026$4,995.00Collaboration Deals in Pharmaceuticals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2020 to 2026
Learn More -
Co-development Deals in Pharmaceuticals and Biotechnology 2016-2026March 2026$3,995.00Analyze co-development deals in pharma and biotech from 2016 to 2026. Includes financials, deal terms, and access to actual contracts where available.
Learn More -
Genomic Collaboration and Licensing Deals 2018-2025November 2025$3,995.00Genomics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2018 to 2025
Learn More -
Royalty Rates in Pharmaceutical and Biotechnology Deals 2015 to 2026March 2026$4,995.00Essential Benchmark Data for Dealmakers | Global coverage | Updated to 2026 | 11+ years of royalty rates | Deal financials | Contract documents | Royalty rate trends
Learn More -
Hospital Care Collaboration and Licensing Deals 2016-2025October 2025$3,995.00Hospital Care Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology 2016-2026March 2026$3,995.00Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2026
Learn More -
Monoclonal Antibody Collaboration and Licensing Deals 2019-2025November 2025$3,995.00Monoclonal Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Cancer Monoclonal Antibody Collaboration and Licensing Deals 2016-2025November 2025$3,995.00Cancer Monoclonal Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Clinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2026March 2026$4,995.00The Clinical Stage Partnering Terms and Agreements in Pharma and Biotech report offers in-depth insights and exclusive access to clinical-stage partnering agreements signed by the world’s leading biopharma companies, providing a detailed analysis of deal structures, financial terms and strategic collaborations.
Learn More
